Monteris Medical and Symphony Robotics today announced a strategic partnership to advance the use of robotics for brain ...
GlobalData on MSN
Monteris and Symphony partner on laser ablation platform
The partnership will integrate Monteris' laser energy delivery systems with Symphony's micro-robotic technology.
Monteris Medical, the leader in laser interstitial thermal therapy (LITT) for use in the brain, and Symphony Robotics, the pioneer in AI-powered micro-robotics, today announced a strategic partnership ...
Children's brain surgeries in Austin can be done with MRI in the operating room with Dell Children's new $22 million ...
Results from a phase 1-2 clinical study (NCT05296122) 1 showed that safety and feasibility measures among patients with primary and recurrent glioblastoma and grade 4 astrocytoma could be met using ...
6don MSN
Innovation in epilepsy care: Alternatives to medication seek to reset, repair brain, expert explains
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
Groundbreaking ultrasound technology is revolutionizing cancer treatment, offering non-invasive alternatives to surgery.
As the chief of pediatric neurosurgery and surgical director of the Pediatric Epilepsy Program at Maria Fareri Children’s ...
MedPage Today on MSN
Stent Graft for Ruptured AAA; Biodegradable PFO Occluder; 24/7 Vascular Service Sued
The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...
Dr explains: What is trigeminal neuralgia and why it’s called the most painful condition in medicine
Trigeminal neuralgia is a chronic condition that causes sudden, electric shock-like facial pain, often triggered by the ...
GlobalData on MSN
Boston Scientific acquires Nalu Medical for $533m
Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results